GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NRX Pharmaceuticals Inc (STU:B1Q) » Definitions » FCF Yield %

NRX Pharmaceuticals (STU:B1Q) FCF Yield % : -46.10 (As of May. 24, 2024)


View and export this data going back to 2020. Start your Free Trial

What is NRX Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, NRX Pharmaceuticals's Trailing 12-Month Free Cash Flow is €-17.79 Mil, and Market Cap is €42.04 Mil. Therefore, NRX Pharmaceuticals's FCF Yield % for today is -46.10%.

The historical rank and industry rank for NRX Pharmaceuticals's FCF Yield % or its related term are showing as below:

STU:B1Q' s FCF Yield % Range Over the Past 10 Years
Min: -121.92   Med: 0   Max: 0
Current: -46.1


STU:B1Q's FCF Yield % is ranked worse than
74.26% of 1554 companies
in the Biotechnology industry
Industry Median: -14.35 vs STU:B1Q: -46.10

NRX Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.


NRX Pharmaceuticals FCF Yield % Historical Data

The historical data trend for NRX Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NRX Pharmaceuticals FCF Yield % Chart

NRX Pharmaceuticals Annual Data
Trend Dec20 Dec21 Dec22 Dec23
FCF Yield %
- -12.90 -56.22 -57.73

NRX Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -53.78 -82.68 -81.56 -34.02 -

Competitive Comparison of NRX Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, NRX Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NRX Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NRX Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where NRX Pharmaceuticals's FCF Yield % falls into.



NRX Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

NRX Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-19.862 / 34.406995
=-57.73%

NRX Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-3.377 * 4 / 0
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NRX Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


NRX Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of NRX Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


NRX Pharmaceuticals (STU:B1Q) Business Description

Traded in Other Exchanges
Address
1201 Orange Street, Suite 600, Wilmington, DE, USA, 19801
NRX Pharmaceuticals Inc is a clinical-stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. It is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behaviour.

NRX Pharmaceuticals (STU:B1Q) Headlines

No Headlines